MELANOMA RESEARCH INSTITUTE (EIN 680263472) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1992

Legal Domicile

Principal Officer

LYNN E SPITLER MD

Phone

4154359861

Tax Period

2022-01-01 to 2022-12-31

MELANOMA RESEARCH INSTITUTE, founded in 1992, is a micro nonprofit that reported $3K in total revenue in fiscal year 2022. Revenue fell 233% from the prior year — a significant decline worth monitoring.

Mission

CONDUCT RESEARCH AIMED AT DEVELOPING A BETTER THERAPY FOR PATIENTS WITH MALIGNANT MELANOMA (INCLUDES MAINTAINING A SOPHISTICATED PATIENT DATABASE DOCUMENTING THE NATURAL COURSE OF THE DISEASE AND THE EFFECTS OF THERAPEUTIC EFFORTS). EDUCATION OF THE PUBLIC, PATIENTS AND THE MEDICAL COMMUNITY ABOUT THE APPROPRIATE DIAGNOSIS AND TREATMENT OF MELANOMA.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $318

Program Service Revenue $0

Investment Income $-3,577

Other Revenue $0

TOTAL REVENUE $-3,259

Expense Breakdown

Grants Paid $50,122

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $52,283

Other Expenses $2,161

TOTAL EXPENSES $52,283

Year-over-Year Comparison

	2022	2021	Change
Revenue	$-3,259	$2,457	-2.3%
Expenses	$52,283	$770	+66.9%
Net Income	$-55,542	$1,687	-33.9%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LYNN E SPITLER MD	PRESIDENT	0.25	Officer	$0	$0	$0
DENNIS FISHER	SECRETARY	0.00	Officer	$0	$0	$0
MELANIE ADAMS	CFO	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$-3,259	$52,283	No data	$-55,542
2021	$2,457	$770	$58,038	$1,687
2020	$4,160	$20,910	$56,433	$-16,750
2019	$23,058	$26,262	$71,097	$-3,204
2018	$2,172	$40,702	$70,828	$-38,530

MELANOMA RESEARCH INSTITUTE